We are live on ! Find out more
RCM

Robinson Capital Management Portfolio holdings

AUM $239M
1-Year Est. Return 0.62%
This Fund
S&P 500
This Quarter Est. Return
+12.99%
1 Year Est. Return
-0.62%
3 Year Est. Return
+1.5%
5 Year Est. Return
-15.5%
10 Year Est. Return
-15.15%
AUM
$281M
AUM Growth
+$56.4M
Cap. Flow
+$28.8M
Cap. Flow %
10.27%
Top 10 Hldgs %
37.66%
Holding
290
New
40
Increased
71
Reduced
84
Closed
66

Top Buys

Rank Stock Value
1
BFK
BlackRock Municipal Income Trust
BFK
+$5.59M
2
BLE
BlackRock Municipal Income Trust II
BLE
+$4.31M
3
VMO icon
Invesco Municipal Opportunity Trust
VMO
+$4.26M
4
IIM icon
Invesco Value Municipal Income Trust
IIM
+$3.63M
5
NMZ icon
Nuveen Municipal High Income Opportunity Fund
NMZ
+$3.19M

Top Sells

Rank Stock Value
1
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$8.25M
2
HYD icon
VanEck High Yield Muni ETF
HYD
+$7.31M
3
TFI icon
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
+$4.64M
4
DSM
BNY Mellon Strategic Municipal Bond Fund
DSM
+$4.47M
5
LEO
BNY Mellon Strategic Municipals
LEO
+$3.06M

Sector Composition

Rank Sector Weight
1 Financials 6.9%
2 Industrials 0.85%
3 Technology 0.37%
4 Healthcare 0.26%
5 Energy 0.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
USARW
176
DELISTED
USA Rare Earth Inc Warrant
USARW
$730 ﹤0.01%
8,106
+3,106
+62% +$446
BZAIW
177
Blaize Holdings Warrants
BZAIW
$6.52M
$723 ﹤0.01%
7,233
-830
-10% -$19
SOAR.WS
178
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
$561 ﹤0.01%
5,052
-422
-8% -$39
BOWNR
179
DELISTED
Bowen Acquisition Corp Rights
BOWNR
$550 ﹤0.01%
+5,000
New +$719
CVIIW
180
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$521 ﹤0.01%
3,450
– –
SDSTW
181
Stardust Power Inc Warrant
SDSTW
$5.67M
$389 ﹤0.01%
4,075
-84
-2% -$3
ESLAW icon
182
Estrella Immunopharma Warrant
ESLAW
$138K
$354 ﹤0.01%
11,805
– –
BHACW
183
DELISTED
Focus Impact BH3 Acquisition Company Warrants
BHACW
$271 ﹤0.01%
3,396
-390
-10% -$16
ADRT
184
DELISTED
Ault Disruptive Technologies Corporation
ADRT
$263 ﹤0.01%
+5,268
New +$61.9K
RCACW
185
DELISTED
Revelstone Capital Acquisition Corp. Warrant
RCACW
$237 ﹤0.01%
5,260
-604
-10% -$25
PRLHW
186
DELISTED
Pearl Holdings Acquisition Corp Warrant
PRLHW
$221 ﹤0.01%
5,520
-634
-10% -$20
IVCAW
187
DELISTED
Investcorp AI Acquisition Corp. Warrant
IVCAW
$184 ﹤0.01%
6,122
-702
-10% -$34
GMFIW
188
DELISTED
Aetherium Acquisition Corp Warrant
GMFIW
$173 ﹤0.01%
4,315
-496
-10% -$23
IVCPW
189
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
$166 ﹤0.01%
3,849
-442
-10% -$24
TGAAW
190
DELISTED
Target Global Acquisition I Corp. Warrant
TGAAW
$162 ﹤0.01%
2,315
-266
-10% -$14
EVE.WS
191
DELISTED
EVe Mobility Acquisition Corp Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EVE.WS
$157 ﹤0.01%
3,916
-448
-10% -$25
BRLSW icon
192
Borealis Foods Inc Warrant
BRLSW
$949K
$148 ﹤0.01%
2,964
-338
-10% -$29
BSLKW
193
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$142 ﹤0.01%
1,092
-124
-10% -$15
PORT.WS
194
DELISTED
Southport Acquisition Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50
PORT.WS
$132 ﹤0.01%
5,278
-606
-10% -$15
AOGOW
195
DELISTED
Arogo Capital Acquisition Corp. Warrant
AOGOW
$109 ﹤0.01%
4,169
-478
-10% -$12
APCA.WS
196
DELISTED
AP Acquisition Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
APCA.WS
$94 ﹤0.01%
3,273
-374
-10% -$10
HAIAW
197
DELISTED
Healthcare AI Acquisition Corp. Warrants
HAIAW
$92 ﹤0.01%
3,639
-416
-10% -$18
AEON.WS
198
DELISTED
AEON Biopharma Inc
AEON.WS
$92 ﹤0.01%
916
-104
-10% -$8
OPTXW icon
199
Syntec Optics Holdings Warrant
OPTXW
$19.2M
$73 ﹤0.01%
662
-74
-10% -$5
FLDDW
200
Fold Holdings Warrant
FLDDW
$1.12M
$70 ﹤0.01%
1,225
-140
-10% -$6
6 7
8
9 10

Similar funds

FWP
Forefront Wealth Partners Austin, Texas $239M AUM 16.12% 1-Year Est. Return
WWA
Wealth Watch Advisors Englewood, Colorado $239M AUM 21.17% 1-Year Est. Return
M
MYeCFO La Jolla, California $239M AUM 18.83% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
DCC
Dow Chemical Company Midland, Michigan $239M AUM 13.16% 1-Year Est. Return
I2I
Insight 2811 Inc Chicago, Illinois $239M AUM 8.89% 1-Year Est. Return
LOM
LTS One Management New York $239M AUM 18.42% 1-Year Est. Return
CCAM
Cascades Capital Asset Management Greensboro, North Carolina $239M AUM 18.43% 1-Year Est. Return

Robinson Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Robinson Capital Management held 290 positions worth $281M, up 25% from $224M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Robinson Capital Management deployed $28.8M of net new capital in Q4 2023, opening 40 new positions and adding to 71 existing holdings. Its largest new stake was Nuveen Municipal High Income Opportunity Fund: 341,384 shares worth $3.38M.

By sector, the portfolio is most concentrated in Financials at 6.9% of assets, down from 9.9% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Pioneer Municipal High Income Fund, an estimated $950K trimmed.

  • Robinson Capital Management's largest Q4 2023 buy was Nuveen Municipal High Income Opportunity Fund: 341,384 shares worth $3.38M.
  • Robinson Capital Management added most to BlackRock Municipal Income Trust in Q4 2023, an estimated $5.59M increase.
  • Robinson Capital Management's biggest Q4 2023 reduction was Pioneer Municipal High Income Fund, cutting an estimated $950K.
  • Robinson Capital Management fully exited Vanguard Tax-Exempt Bond Index Fund in Q4 2023, selling an estimated $8.25M.
  • Robinson Capital Management's ten largest holdings make up 38% of its $281M portfolio in Q4 2023.
  • Robinson Capital Management opened 40 new positions and closed 66 in Q4 2023.
  • Robinson Capital Management's portfolio value rose 25% quarter-over-quarter to $281M.

Based on Robinson Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.